Yu Yinan, Dong Jing, Xu Zifeng, Shen Hao, Zheng Jijian
Department of Anesthesiology, Shanghai Jiaotong University Affiliated Shanghai First People's Hospital, Shanghai, China.
J Clin Monit Comput. 2015 Feb;29(1):47-52. doi: 10.1007/s10877-014-9567-5. Epub 2014 Feb 21.
Pleth variability index (PVI), a noninvasive dynamic indicator of fluid responsiveness has been demonstrated to be useful in the management of the patients with goal directed fluid therapy under general anesthesia, but whether PVI can be used to optimize fluid management under combined general and epidural anesthesia (GEN-EPI) remains to be elucidated. The aim of our study was to explore the impact of PVI as a goal-directed fluid therapy parameter on the tissue perfusion for patients with GEN-EPI. Thirty ASA I-II patients scheduled for major abdominal surgeries under GEN-EPI were randomized into PVI-directed fluid management group (PVI group) and non PVI-directed fluid management group (control group). 2 mL/kg/h crystalloid fluid infusion was maintained in PVI group, once PVI>13%, a 250 mL colloid or crystalloid was rapidly infused. 4-8 mL/kg/h crystalloid fluid infusion was maintained in control group, and quick fluid infusion was initiated if mean arterial blood pressure (BP)<65 mmHg. Small doses of norepinephrine were given to keep mean arterial BP above 65 mmHg as needed in both groups. Perioperative lactate levels, hemodynamic changes were recorded individually. The total amount of intraoperative fluids, the amount of crystalloid fluid and the first hour blood lactate levels during surgery were significantly lower in PVI than control group, P<0.05. PVI-based goal-directed fluid management can reduce the intraoperative fluid amount and blood lactate levels in patients under GEN-EPI, especially the crystalloid. Furthermore, the first hour following GEN-EPI might be the critical period for anesthesiologist to optimize the fluid management.
脉压变异指数(PVI)是一种用于评估液体反应性的非侵入性动态指标,已被证明在全身麻醉下目标导向液体治疗的患者管理中有用,但PVI是否可用于优化全身麻醉联合硬膜外麻醉(GEN-EPI)下的液体管理仍有待阐明。我们研究的目的是探讨PVI作为目标导向液体治疗参数对GEN-EPI患者组织灌注的影响。30例计划在GEN-EPI下进行腹部大手术的ASA I-II级患者被随机分为PVI导向液体管理组(PVI组)和非PVI导向液体管理组(对照组)。PVI组维持2 mL/kg/h的晶体液输注,一旦PVI>13%,则快速输注250 mL胶体液或晶体液。对照组维持4-8 mL/kg/h的晶体液输注,若平均动脉压(BP)<65 mmHg则开始快速补液。两组均根据需要给予小剂量去甲肾上腺素以维持平均动脉压高于65 mmHg。分别记录围手术期乳酸水平、血流动力学变化。PVI组术中液体总量、晶体液量及手术开始后第1小时血乳酸水平均显著低于对照组,P<0.05。基于PVI的目标导向液体管理可减少GEN-EPI患者术中液体量及血乳酸水平,尤其是晶体液。此外,GEN-EPI后的第1小时可能是麻醉医生优化液体管理的关键时期。